Fudan University: Endometrial Neoplasms trials
The registry lists 10 Endometrial Neoplasms studies with Fudan University as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 2 8Phase 3 4No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular ClassificationRecruitingNCT07319429Phase 2/3
- TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd ECRecruitingNCT06914297Phase 2
- Oral Topotecan With Toripalimab for Patients With Endometrial CancerNot yet recruitingNCT06548763Phase 2
- Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutationNot yet recruitingNCT05489848Phase 2/3
- Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMPTerminatedNCT05454358Phase 2/3
- Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial CancerActive, not recruitingNCT05247268Phase 2
- Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial CarcinomaCompletedNCT04491643Phase 2
- Evaluation of the Efficacy for Sentinel Lymph Node Policy in High-risk Endometrial CarcinomaCompletedNCT03716414
- Evaluation of the Efficacy for Sentinel Lymph Node Policy in Intermediate-risk Endometrial CarcinomasWithdrawnNCT03677024Not applicable
- Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial CancerCompletedNCT03241914Phase 2/3